425 ·Filed Jul 7, 2026

ONCO

Onconetix, Inc.
NEUTRAL
Impact 2/10
Horizonmonths Processed2mo ago SEC0001213900-26-075776
Rule 425 M&A communications
Actionable Insight • Neutral

No immediate catalyst from this filing. The acquisition remains in progress with no updated terms or timeline. Monitor for shareholder vote and S-4 filing for definitive deal economics.

DirectionNeutral
Confidencemedium
Horizonmonths
Final — all horizons settled through T+60d
ONCO ▼ -26.89% at T+60d
NEUTRAL call ✗ call lost -26.89% · α vs SPY -28.88% · entry $1.07 → $0.7823
Entry anchored
Jul 7, 09:01 AM ET
via exchange tick
T+1d
-10.50%
call -10.50% · α -10.19%
$0.9577
settled 3mo ago
T+5d
-20.68%
call -20.68% · α -21.23%
$0.8487
settled 3mo ago
T+20d
-24.20%
call -24.20% · α -25.53%
$0.8111
settled 2mo ago
T+60d
-26.89%
call -26.89% · α -28.88%
$0.7823
settled 3d ago

Price Chart

Loading chart...

Executive Summary

Onconetix highlights a new partnership between its acquisition target Realbotix and Bloom Services for a UK pilot deploying humanoid robots to combat elderly social isolation. Realbotix also becomes an accredited supplier on Bloom's public sector marketplace. This is a routine promotional update on the target's commercial traction; no changes to the pending all-stock acquisition terms or timeline.

Key Financial Metrics

Deal Type
acquisition

Key Facts

  • Realbotix partners with Bloom Procurement Services for a UK pilot using humanoid robots in elderly care settings in Northeast England.
  • Realbotix accredited as a supplier on Bloom's public sector marketplace, creating a procurement route for UK public sector organizations.
  • Onconetix's pending acquisition of Realbotix LLC remains an all-stock transaction expected to close in H2 2026, subject to shareholder and regulatory approvals.
  • This is the second promotional 425 filing in two weeks highlighting Realbotix commercial progress, following a June 24 filing about an AI teacher's assistant pilot.

Financial Impact

No financial figures disclosed. The pilot program and supplier accreditation are non-material commercial developments.

Risk Factors

  • Deal may fail to close if shareholder approval or regulatory approvals are not obtained.
  • Onconetix's current $4M market cap and heavy historical stock decline suggest high execution risk for the combined entity.
  • Realbotix's commercial pilots are early-stage and may not translate into material revenue.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001213900-26-075776
Document: 0001213900-26-075776-index-headers.html0001213900-26-075776
Document: 0001213900-26-075776-index.html0001213900-26-075776
Document: 0001213900-26-075776.txt0001213900-26-075776
22 reports for ONCO
Performance horizon
67% Hit rate 8 of 12 directional calls best @ T+60▲ +78.04%May 8, 2026
Filters
Rows
Reports for ONCO — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
DEFA14A / 8-K
NEUTRAL ★ 4/10
$0.6374 $0.6549▲ +2.75%▲ +2.64%$0.7440 (+16.72%)
Sep 14, 2026
18d ago
8-K
BEARISH ★ 6/10
$0.6374 $0.6549▼ −2.75%▼ −2.64%$0.7440 (−16.72%)
Sep 14, 2026
18d ago
425
BEARISH ★ 6/10
$0.6374 $0.6549▼ −2.75%▼ −2.64%$0.7440 (−16.72%)
Sep 4, 2026
28d ago
EFFECT
BEARISH ★ 8/10
$1.02 $0.6374▲ +37.51%▲ +36.30%$0.7440 (+27.06%)
Sep 3, 2026
29d ago
425
NEUTRAL ★ 3/10
$0.7390 $0.7564▲ +2.35%▲ +3.50%$0.7440 (+0.68%)
Aug 31, 2026
4w ago
S-1/A
BEARISH ★ 8/10
$0.6528 $0.8132▼ −24.57%▼ −24.49%$0.7440 (−13.97%)
Aug 12, 2026
7w ago
S-1
BEARISH ★ 8/10
$0.8920 $0.7110▲ +20.29%▲ +19.85%$0.7440 (+16.59%)
Jul 29, 2026
9w ago
8-K
BEARISH ★ 8/10
$0.7864 $0.9037▼ −14.92%▼ −11.29%$0.7440 (+5.39%)
Jul 7, 2026
12w ago
425
NEUTRAL ★ 2/10
$1.07 $0.8487▼ −20.68%▼ −21.23%$0.7440 (−30.47%)
Jun 17, 2026
15w ago
EFFECT
BEARISH ★ 6/10
$0.9949 $1.00▼ −0.51%▼ −1.55%$0.7440 (+25.22%)
Showing 10 of 22

US Market Status

Market Closed — Opens Mon (37h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access